Acetaminophen Dextromethorphan Hydrobromide Diphen

證據等級: L5

預測適應症: 0 個

Acetaminophen / Dextromethorphan Hydrobromide / Diphenhydramine: No Repurposing Predictions Available

One-Sentence Summary

Acetaminophen / Dextromethorphan Hydrobromide / Diphenhydramine is a three-component OTC combination typically used for cold and flu symptom relief — covering fever, cough, and nasal congestion or sleep disturbance. The TxGNN model returned no predicted new indications for this combination drug entry. Evaluation cannot proceed substantively until predictions are generated and missing data gaps are resolved.

Quick Overview

Item	Content
Original Indication	Cold and flu symptom relief (analgesic/antipyretic + antitussive + antihistamine)
Predicted New Indication	None available
TxGNN Prediction Score	N/A
Evidence Level	N/A — no predictions generated
Taiwan Market Status	未上市 (Not marketed)
Number of Licensed Products	0
Recommended Decision	Hold

Why No Predictions Were Generated

This Evidence Pack contains an empty predicted_indications array, which means the TxGNN pipeline did not produce any repurposing candidates for this drug entry. Two likely reasons account for this:

1. Multi-component combination string was used as the query key. TxGNN’s knowledge graph maps individual chemical entities (single INN) to DrugBank nodes. The compound query string "ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DIPHENHYDRAMINE" does not match any single node in the knowledge graph, so no score is computed. The three ingredients would need to be queried individually.

2. No DrugBank ID was resolved. The drugbank_id field is null, confirming that entity resolution failed. Without a valid DrugBank node, neither the KG-based method nor the DL-based method can produce predictions.

The DrugBank query log shows one result was returned (result_count: 1), but this data was not propagated into the Evidence Pack — likely a pipeline parsing issue that should be investigated.

Taiwan Market Information

No licensed products were found in the Taiwan regulatory database for this combination string. This may reflect:

The combination is not registered as a fixed-dose combination product in Taiwan
The query was run against the full combination name rather than individual ingredients

Individual active ingredients (acetaminophen, dextromethorphan, diphenhydramine) are widely available as separate or smaller combination OTC products in Taiwan under various brand names, but these are not captured in the current query.

Conclusion and Next Steps

Decision: Hold

Rationale: The TxGNN model produced no repurposing predictions for this entry because the combination drug string could not be resolved to a DrugBank node. There is no prediction basis, no original indication data in the Evidence Pack, and no MOA data — making a repurposing evaluation impossible at this stage.

To proceed, the following is needed:

Disaggregate the query: Re-run the TxGNN pipeline for each active ingredient separately — ACETAMINOPHEN (DB00316), DEXTROMETHORPHAN (DB00514), and DIPHENHYDRAMINE (DB01075) — to obtain individual prediction scores and ranked disease candidates
Resolve the DrugBank data gap: The DrugBank collector returned 1 result but it was not populated into the Evidence Pack; trace the pipeline step and fix the data propagation error
Retrieve MOA for each ingredient: Query DrugBank API for mechanism of action of all three components to enable mechanistic plausibility analysis
Clarify target market: Confirm whether the regulatory query should target Taiwan (TFDA) or another jurisdiction, and rerun with individual ingredient names
Obtain package insert safety data: Download and parse the TFDA package insert PDF to fill the blocking data gap (DG001) before any safety screening can proceed
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.